1. IMDRF. Methodological principles in the use of international medical device registry data. Contract No.: IMDRF/Registry WG/N42FINAL:2017. 2017.
2. U.S. Food and Drug Administration. Strengthening our national system for medical device postmarket surveillance. 2013. Available from: https://www.fda.gov/files/about%20fda/published/Strengthening-Our-National-System-for-Medical-Device-Postmarket-Surveillance.pdf. Accessed January 13, 2021.
3. A Description of Signals During the First 18 Months of the EMA Pharmacovigilance Risk Assessment Committee
4. European Medicines Agency. Guideline on Good Pharmacovigilance Practices. Module IX: signal management; 2012.
5. Commission Implementing Regulation (EU) No 520/2012. 2012.